Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy (Q33180853)

23 July 2017

Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy (English)

1 reference

23 July 2017

0 references

ventricular dysfunction

1 reference

left ventricular dysfunction

inferred from title

1 reference

Cardinale D

1

1 reference

23 July 2017

Sandri MT

2

1 reference

23 July 2017

Martinoni A

3

1 reference

23 July 2017

Tricca A

4

1 reference

23 July 2017

Civelli M

5

1 reference

23 July 2017

Lamantia G

6

1 reference

23 July 2017

Cinieri S

7

1 reference

23 July 2017

Martinelli G

8

1 reference

23 July 2017

Cipolla CM

9

1 reference

23 July 2017

Fiorentini C

10

1 reference

23 July 2017

language of work or name

English

0 references

publication date

1 August 2000

1 reference

Journal of the American College of Cardiology

23 July 2017

1 reference

23 July 2017

36

1 reference

23 July 2017

517-522

1 reference

23 July 2017

2

1 reference

Consensus Conference on Intensive Chemotherapy Plus Hematopoietic Stem-Cell Transplantation in Malignancies: Lyon, France, June 4-6, 1993.

23 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900748-8

7 January 2021

Prognostic factors for prolonged progression-free survival with high-dose chemotherapy with autologous stem-cell support for advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900748-8

7 January 2021

High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900748-8

7 January 2021

Cardiac effects of high-dose epirubicin and cyclophosphamide in women with poor prognosis breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900748-8

7 January 2021

Phase II trial of high-dose liposome-encapsulated doxorubicin with granulocyte colony-stimulating factor in metastatic breast cancer. TLC D-99 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900748-8

7 January 2021

Anthracyclines and the heart

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900748-8

7 January 2021

Doxorubicin cardiac toxicity manifesting seven years after treatment. Case report and review

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900748-8

7 January 2021

Cardiac toxicity 4 to 20 years after completing anthracycline therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900748-8

7 January 2021

Reversibility of severe left ventricular dysfunction due to doxorubicin cardiotoxicity. Report of three cases

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900748-8

7 January 2021

The Prognostic Value of Serum Troponin T in Unstable Angina

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900748-8

7 January 2021

Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900748-8

7 January 2021

Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900748-8

7 January 2021

Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease. TRIM Study Group. Thrombin Inhibition in Myocardial ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900748-8

7 January 2021

Cardiotoxicity of chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900748-8

7 January 2021

Drug-induced heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900748-8

7 January 2021

Prolonged disease-free survival after high-dose sequential chemo-radiotherapy and haemopoietic autologous transplantation in poor prognosis Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900748-8

7 January 2021

Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900748-8

7 January 2021

Prevention of adriamycin cardiotoxicity by niacin, isocitrate or N-acetyl-cysteine in mice. A morphological study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900748-8

7 January 2021

Assessment of anthracycline-induced myocardial damage by quantitative indium 111 myosin-specific monoclonal antibody studies

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900748-8

7 January 2021

Detection of adriamycin cardiotoxicity with indium-111 labeled antimyosin monoclonal antibody imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900748-8

7 January 2021

Cardiovascular autonomic function in anthracycline-treated breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900748-8

7 January 2021

A new insight into adriamycin-induced cardiotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900748-8

7 January 2021

Toxic effects of daunorubicin on isolated and cultured heart cells from neonatal rats

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900748-8

7 January 2021

Doxorubicin toxicity in perfused rat heart. Decreased cell death at low oxygen tension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900748-8

7 January 2021

Severe and fatal anthracycline cardiotoxicity at cumulative doses below 400 mg/m2: evidence for enhanced toxicity with multiagent chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900748-8

7 January 2021

Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900748-8

7 January 2021

10.1016/S0735-1097(00)00748-8

Identifiers

DOI

1 reference

23 July 2017

1 reference